Symbol:
Nr5a2
Name:
nuclear receptor subfamily 5, group A, member 2
RGD ID:
68353
Description:
Enables double-stranded DNA binding activity and nuclear receptor activity. Involved in calcineurin-mediated signaling. Predicted to be located in cytoplasm. Predicted to be part of RNA polymerase II transcription regulator complex. Predicted to be active in nucleus. Orthologous to human NR5A2 (nuclear receptor subfamily 5 group A member 2); PARTICIPATES IN maturity-onset diabetes of the young pathway; INTERACTS WITH 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane; 17alpha-ethynylestradiol; 17beta-estradiol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
fetoprotein transcription factor; Ftf; FTZ-F1 beta; FTZ-F1 beta2 protein; liver receptor homolog 1; Lrh-1; nuclear receptor subfamily 5 group A member 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
NR5A2 (nuclear receptor subfamily 5 group A member 2)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OrthoDB, Panther, PhylomeDB
Mus musculus (house mouse):
Nr5a2 (nuclear receptor subfamily 5, group A, member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Nr5a2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
NR5A2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
NR5A2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Nr5a2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
NR5A2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LOC103230356 (uncharacterized LOC103230356)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Nr5a2 (nuclear receptor subfamily 5 group A member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
NR5A2 (nuclear receptor subfamily 5 group A member 2)
Alliance
DIOPT (HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Nr5a2 (nuclear receptor subfamily 5, group A, member 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
nr5a2 (nuclear receptor subfamily 5, group A, member 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
nhr-25
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
ftz-f1
Alliance
DIOPT (InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
nr5a2
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 50,865,253 - 50,985,107 (-) NCBI GRCr8 mRatBN7.2 13 48,313,634 - 48,433,494 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 48,316,301 - 48,433,326 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 50,924,322 - 51,041,371 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 52,212,210 - 52,329,237 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 49,479,256 - 49,596,284 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 53,750,470 - 53,870,288 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 53,750,473 - 53,870,428 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 58,791,496 - 58,910,967 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 49,931,592 - 50,048,756 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 13 49,945,671 - 50,062,836 (-) NCBI Celera 13 48,623,262 - 48,740,634 (-) NCBI Celera Cytogenetic Map 13 q13 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Nr5a2 Rat (-)-demecolcine increases expression ISO NR5A2 (Homo sapiens) 6480464 Demecolcine results in increased expression of NR5A2 mRNA CTD PMID:23649840 Nr5a2 Rat (1->4)-beta-D-glucan multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NR5A2 mRNA CTD PMID:36331819 Nr5a2 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 Nr5a2 Rat 1,2-dilauroyl-sn-glycero-3-phosphocholine(1+) increases expression ISO Nr5a2 (Mus musculus) 6480464 1 and 2-dilauroylphosphatidylcholine results in increased expression of NR5A2 CTD PMID:24459144 Nr5a2 Rat 1-O-oleoyl-sn-glycero-3-phosphocholine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of 1-oleoyl lysophosphatidylcholine CTD PMID:29515023 Nr5a2 Rat 17alpha-ethynylestradiol increases expression ISO Nr5a2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of NR5A2 mRNA CTD PMID:17942748 Nr5a2 Rat 17alpha-ethynylestradiol multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA CTD PMID:17942748 Nr5a2 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NR5A2 mRNA CTD PMID:15834898 Nr5a2 Rat 17beta-estradiol increases expression ISO NR5A2 (Homo sapiens) 6480464 Estradiol results in increased expression of NR5A2 mRNA CTD PMID:20607599 more ... Nr5a2 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA CTD PMID:32741896 Nr5a2 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of NR5A2 mRNA CTD PMID:32145629 Nr5a2 Rat 17beta-estradiol decreases abundance ISO Nr5a2 (Mus musculus) 6480464 NR5A2 protein results in decreased abundance of Estradiol CTD PMID:18628394 Nr5a2 Rat 17beta-estradiol multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [[NR5A2 protein results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estradiol and [NR5A2 results in increased expression of NOS3 mRNA] which results in decreased abundance of Estradiol CTD PMID:18628394 Nr5a2 Rat 17beta-estradiol decreases expression ISO NR5A2 (Homo sapiens) 6480464 Estradiol results in decreased expression of NR5A2 mRNA and Estradiol results in decreased expression of NR5A2 protein CTD PMID:20106945 and PMID:33181973 Nr5a2 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA CTD PMID:32741896 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Nr5a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:24058054 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:33387578 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:32109520 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO NR5A2 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA] CTD PMID:29704546 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Nr5a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:29452137 and PMID:37172768 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nr5a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NR5A2 mRNA CTD PMID:21570461 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA more ... CTD PMID:17942748 more ... Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO NR5A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:20106945 and PMID:29704546 Nr5a2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO NR5A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:17517823 Nr5a2 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Nr5a2 Rat 2-methoxyethanol multiple interactions EXP 6480464 Bromocriptine affects the reaction [methyl cellosolve results in increased expression of NR5A2 mRNA] CTD PMID:21427058 Nr5a2 Rat 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of NR5A2 mRNA CTD PMID:21427058 Nr5a2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Nr5a2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of NR5A2 mRNA CTD PMID:18648102 Nr5a2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Nr5a2 (Mus musculus) 6480464 bisphenol S results in decreased expression of NR5A2 mRNA CTD PMID:39298647 Nr5a2 Rat 4,4'-sulfonyldiphenol multiple interactions ISO NR5A2 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 Nr5a2 Rat 4,4'-sulfonyldiphenol decreases expression ISO NR5A2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of NR5A2 protein CTD PMID:33181973 Nr5a2 Rat 5-fluorouracil affects expression ISO Nr5a2 (Mus musculus) 6480464 Fluorouracil affects the expression of NR5A2 protein CTD PMID:21296659 Nr5a2 Rat 9-cis-retinoic acid decreases expression ISO NR5A2 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of NR5A2 mRNA CTD PMID:16357189 Nr5a2 Rat 9-cis-retinoic acid multiple interactions ISO NR5A2 (Homo sapiens) 6480464 Alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] and Alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 Nr5a2 Rat acetic acid decreases expression ISO Nr5a2 (Mus musculus) 6480464 Acetic Acid results in decreased expression of NR5A2 protein CTD PMID:21296659 Nr5a2 Rat aflatoxin B1 affects expression ISO NR5A2 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of NR5A2 protein CTD PMID:20106945 Nr5a2 Rat aflatoxin B1 increases methylation ISO NR5A2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of NR5A2 intron CTD PMID:30157460 Nr5a2 Rat aflatoxin B1 decreases methylation ISO NR5A2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of NR5A2 gene CTD PMID:27153756 Nr5a2 Rat aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of NR5A2 mRNA CTD PMID:25450479 Nr5a2 Rat Aflatoxin B2 alpha decreases methylation ISO NR5A2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of NR5A2 intron CTD PMID:30157460 Nr5a2 Rat all-trans-retinoic acid increases expression ISO NR5A2 (Homo sapiens) 6480464 Tretinoin results in increased expression of NR5A2 mRNA CTD PMID:21934132 Nr5a2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NR5A2 mRNA CTD PMID:16483693 Nr5a2 Rat androst-4-ene-3,17-dione increases expression EXP 6480464 Androstenedione results in increased expression of NR5A2 mRNA CTD PMID:21273442 Nr5a2 Rat androst-4-ene-3,17-dione multiple interactions EXP 6480464 AR mutant form inhibits the reaction [Androstenedione results in increased expression of NR5A2 mRNA] CTD PMID:21273442 Nr5a2 Rat arachidonic acid multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in decreased abundance of Arachidonic Acid analog CTD PMID:29515023 Nr5a2 Rat arachidonic acid decreases chemical synthesis ISO Nr5a2 (Mus musculus) 6480464 NR5A2 gene mutant form results in decreased chemical synthesis of Arachidonic Acid CTD PMID:29515023 Nr5a2 Rat arsane affects methylation ISO NR5A2 (Homo sapiens) 6480464 Arsenic affects the methylation of NR5A2 gene CTD PMID:25304211 Nr5a2 Rat arsenic atom affects methylation ISO NR5A2 (Homo sapiens) 6480464 Arsenic affects the methylation of NR5A2 gene CTD PMID:25304211 Nr5a2 Rat arsenite(3-) increases methylation ISO NR5A2 (Homo sapiens) 6480464 arsenite results in increased methylation of NR5A2 promoter CTD PMID:23974009 Nr5a2 Rat arsenite(3-) decreases expression ISO NR5A2 (Homo sapiens) 6480464 arsenite results in decreased expression of NR5A2 mRNA CTD PMID:31646340 Nr5a2 Rat atrazine increases activity ISO NR5A2 (Homo sapiens) 6480464 Atrazine results in increased activity of NR5A2 protein CTD PMID:18461179 Nr5a2 Rat Azoxymethane multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 Nr5a2 Rat aztreonam increases expression ISO Nr5a2 (Mus musculus) 6480464 Aztreonam results in increased expression of NR5A2 mRNA CTD PMID:24657338 Nr5a2 Rat benzo[a]pyrene affects methylation ISO NR5A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of NR5A2 intron CTD PMID:30157460 Nr5a2 Rat benzo[a]pyrene decreases expression ISO NR5A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of NR5A2 mRNA CTD PMID:32234424 Nr5a2 Rat benzo[e]pyrene decreases methylation ISO NR5A2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of NR5A2 intron CTD PMID:30157460 Nr5a2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Nr5a2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of NR5A2 mRNA CTD PMID:25975992 Nr5a2 Rat bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of NR5A2 mRNA CTD PMID:29945229 Nr5a2 Rat bisphenol A increases expression ISO Nr5a2 (Mus musculus) 6480464 bisphenol A results in increased expression of NR5A2 mRNA CTD PMID:26063408 and PMID:30951980 Nr5a2 Rat bisphenol A increases expression ISO NR5A2 (Homo sapiens) 6480464 bisphenol A results in increased expression of NR5A2 mRNA CTD PMID:36232920 Nr5a2 Rat bisphenol A decreases expression ISO NR5A2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of NR5A2 protein CTD PMID:33181973 Nr5a2 Rat bisphenol A multiple interactions ISO NR5A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 Nr5a2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NR5A2 mRNA CTD PMID:34947998 Nr5a2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NR5A2 mRNA CTD PMID:30816183 and PMID:32528016 Nr5a2 Rat bisphenol A affects methylation ISO Nr5a2 (Mus musculus) 6480464 bisphenol A affects the methylation of NR5A2 promoter CTD PMID:27334623 Nr5a2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NR5A2 gene CTD PMID:28505145 Nr5a2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NR5A2 mRNA CTD PMID:25181051 and PMID:32145629 Nr5a2 Rat bisphenol F increases expression ISO Nr5a2 (Mus musculus) 6480464 bisphenol F results in increased expression of NR5A2 mRNA CTD PMID:38685157 Nr5a2 Rat bromochloroacetic acid increases expression ISO Nr5a2 (Mus musculus) 6480464 bromochloroacetic acid results in increased expression of NR5A2 protein CTD PMID:21296659 Nr5a2 Rat bromocriptine multiple interactions EXP 6480464 Bromocriptine affects the reaction [methyl cellosolve results in increased expression of NR5A2 mRNA] CTD PMID:21427058 Nr5a2 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of NR5A2 mRNA CTD PMID:19167457 Nr5a2 Rat cadmium atom increases expression ISO NR5A2 (Homo sapiens) 6480464 Cadmium results in increased expression of NR5A2 mRNA CTD PMID:31646340 Nr5a2 Rat carbon nanotube decreases expression ISO Nr5a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Nr5a2 Rat cefalotin multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA CTD PMID:24657338 Nr5a2 Rat cholesterol affects abundance ISO Nr5a2 (Mus musculus) 6480464 NR5A2 gene mutant form affects the abundance of Cholesterol CTD PMID:29515023 Nr5a2 Rat choline multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 Nr5a2 Rat cisplatin decreases expression ISO NR5A2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of NR5A2 mRNA CTD PMID:27392435 Nr5a2 Rat clofibrate increases expression ISO Nr5a2 (Mus musculus) 6480464 Clofibrate results in increased expression of NR5A2 mRNA CTD PMID:28973556 Nr5a2 Rat cobalt dichloride decreases expression ISO NR5A2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of NR5A2 mRNA CTD PMID:19320972 Nr5a2 Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NR5A2 mRNA CTD PMID:24386269 Nr5a2 Rat colforsin daropate hydrochloride multiple interactions ISO NR5A2 (Homo sapiens) 6480464 alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] and NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 Nr5a2 Rat colforsin daropate hydrochloride increases expression ISO NR5A2 (Homo sapiens) 6480464 Colforsin results in increased expression of NR5A2 mRNA CTD PMID:16357189 Nr5a2 Rat crocidolite asbestos increases methylation ISO NR5A2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased methylation of NR5A2 gene CTD PMID:29523930 Nr5a2 Rat cyclosporin A decreases expression ISO NR5A2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NR5A2 mRNA CTD PMID:20106945 and PMID:27989131 Nr5a2 Rat dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of NR5A2 mRNA CTD PMID:20888898 Nr5a2 Rat dextran sulfate multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 Nr5a2 Rat dibenz[a,h]anthracene increases expression ISO Nr5a2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Nr5a2 Rat diethylstilbestrol increases expression ISO Nr5a2 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of NR5A2 mRNA CTD PMID:22100434 Nr5a2 Rat Diosbulbin B decreases expression ISO Nr5a2 (Mus musculus) 6480464 diosbulbin B results in decreased expression of NR5A2 mRNA CTD PMID:32148032 Nr5a2 Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NR5A2 mRNA CTD PMID:33729688 Nr5a2 Rat endosulfan affects expression EXP 6480464 Endosulfan affects the expression of NR5A2 mRNA CTD PMID:29391264 Nr5a2 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NR5A2 mRNA CTD PMID:24793618 Nr5a2 Rat folic acid multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 Nr5a2 Rat formaldehyde increases expression ISO NR5A2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of NR5A2 mRNA CTD PMID:23649840 Nr5a2 Rat fulvestrant increases expression ISO NR5A2 (Homo sapiens) 6480464 Fulvestrant results in increased expression of NR5A2 mRNA CTD PMID:31646340 Nr5a2 Rat fulvestrant multiple interactions ISO NR5A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 Nr5a2 Rat genistein increases expression ISO Nr5a2 (Mus musculus) 6480464 Genistein results in increased expression of NR5A2 mRNA CTD PMID:22553218 Nr5a2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NR5A2 mRNA CTD PMID:33387578 Nr5a2 Rat imipenem hydrate multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA CTD PMID:24657338 Nr5a2 Rat L-methionine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 Nr5a2 Rat lead nitrate increases expression ISO Nr5a2 (Mus musculus) 6480464 lead nitrate results in increased expression of NR5A2 mRNA CTD PMID:16049268 Nr5a2 Rat linoleic acid multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Linoleic Acid analog CTD PMID:29515023 Nr5a2 Rat lipopolysaccharide multiple interactions ISO NR5A2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Nr5a2 Rat lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of NR5A2 mRNA CTD PMID:20888898 Nr5a2 Rat lysophosphatidylcholine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Lysophosphatidylcholines CTD PMID:29515023 Nr5a2 Rat lysophosphatidylethanolamine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of lysophosphatidylethanolamine and [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of lysophosphatidylethanolamine analog CTD PMID:29515023 Nr5a2 Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of NR5A2 mRNA CTD PMID:30467583 Nr5a2 Rat methapyrilene decreases methylation ISO NR5A2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of NR5A2 intron CTD PMID:30157460 Nr5a2 Rat methylmercury chloride increases expression ISO NR5A2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of NR5A2 mRNA CTD PMID:23903816 Nr5a2 Rat N-methyl-4-phenylpyridinium decreases expression ISO NR5A2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NR5A2 mRNA CTD PMID:24810058 Nr5a2 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of NR5A2 mRNA] CTD PMID:17106253 Nr5a2 Rat N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of NR5A2 mRNA CTD PMID:17106253 Nr5a2 Rat neomycin multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA CTD PMID:24657338 Nr5a2 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of NR5A2 mRNA CTD PMID:26720608 Nr5a2 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of NR5A2 mRNA CTD PMID:33484710 Nr5a2 Rat obeticholic acid decreases expression ISO NR5A2 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of NR5A2 mRNA CTD PMID:27939613 Nr5a2 Rat ozone decreases expression ISO Nr5a2 (Mus musculus) 6480464 Ozone results in decreased expression of NR5A2 mRNA CTD PMID:16183385 Nr5a2 Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of NR5A2 mRNA CTD PMID:27638505 Nr5a2 Rat paracetamol decreases expression ISO Nr5a2 (Mus musculus) 6480464 Acetaminophen results in decreased expression of NR5A2 mRNA CTD PMID:17585979 Nr5a2 Rat paracetamol multiple interactions ISO Nr5a2 (Mus musculus) 6480464 YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of NR5A2 mRNA] CTD PMID:34546377 Nr5a2 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NR5A2 mRNA CTD PMID:33387578 Nr5a2 Rat paracetamol decreases expression ISO NR5A2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of NR5A2 mRNA CTD PMID:21420995 and PMID:29067470 Nr5a2 Rat paracetamol affects expression ISO Nr5a2 (Mus musculus) 6480464 Acetaminophen affects the expression of NR5A2 mRNA CTD PMID:17562736 Nr5a2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NR5A2 mRNA CTD PMID:36331819 Nr5a2 Rat phenobarbital multiple interactions ISO Nr5a2 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NR5A2 mRNA] CTD PMID:19482888 Nr5a2 Rat phenobarbital affects expression ISO Nr5a2 (Mus musculus) 6480464 Phenobarbital affects the expression of NR5A2 mRNA CTD PMID:23091169 Nr5a2 Rat phenobarbital increases expression ISO Nr5a2 (Mus musculus) 6480464 Phenobarbital results in increased expression of NR5A2 mRNA CTD PMID:19482888 Nr5a2 Rat phorbol 13-acetate 12-myristate multiple interactions ISO NR5A2 (Homo sapiens) 6480464 alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] and NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 Nr5a2 Rat phosphatidylcholine multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Phosphatidylcholines CTD PMID:29515023 Nr5a2 Rat pirinixic acid decreases expression ISO Nr5a2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of NR5A2 mRNA CTD PMID:18445702 Nr5a2 Rat potassium dichromate decreases expression ISO Nr5a2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of NR5A2 mRNA CTD PMID:23608068 Nr5a2 Rat pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of NR5A2 mRNA CTD PMID:20888898 Nr5a2 Rat progesterone decreases abundance ISO Nr5a2 (Mus musculus) 6480464 NR5A2 gene mutant form results in decreased abundance of Progesterone CTD PMID:17409375 Nr5a2 Rat progesterone increases abundance ISO Nr5a2 (Mus musculus) 6480464 NR5A2 protein results in increased abundance of Progesterone CTD PMID:18628394 Nr5a2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO NR5A2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Nr5a2 Rat sodium arsenite decreases expression ISO NR5A2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of NR5A2 mRNA CTD PMID:29301061 and PMID:34032870 Nr5a2 Rat succimer multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NR5A2 mRNA CTD PMID:26378955 Nr5a2 Rat sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of NR5A2 mRNA CTD PMID:25450479 Nr5a2 Rat sulpiride increases expression EXP 6480464 Sulpiride results in increased expression of NR5A2 mRNA CTD PMID:21427058 Nr5a2 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA more ... CTD PMID:21273442 and PMID:32741896 Nr5a2 Rat testosterone increases expression EXP 6480464 Testosterone results in increased expression of NR5A2 mRNA CTD PMID:21273442 Nr5a2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NR5A2 mRNA CTD PMID:31150632 Nr5a2 Rat tetrachloromethane decreases expression ISO Nr5a2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of NR5A2 mRNA CTD PMID:31919559 Nr5a2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of NR5A2 mRNA CTD PMID:34492290 Nr5a2 Rat titanium dioxide multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 Nr5a2 Rat titanium dioxide decreases methylation ISO Nr5a2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NR5A2 gene CTD PMID:35295148 Nr5a2 Rat trichloroethene multiple interactions ISO Nr5a2 (Mus musculus) 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of NR5A2 mRNA] CTD PMID:15363585 Nr5a2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NR5A2 mRNA CTD PMID:33387578 Nr5a2 Rat ursodeoxycholic acid increases expression ISO Nr5a2 (Mus musculus) 6480464 Ursodeoxycholic Acid results in increased expression of NR5A2 mRNA CTD PMID:18687751 Nr5a2 Rat ursodeoxycholic acid multiple interactions ISO Nr5a2 (Mus musculus) 6480464 NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of NR5A2 mRNA] CTD PMID:18687751 Nr5a2 Rat valproic acid increases expression ISO NR5A2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NR5A2 mRNA CTD PMID:24935251 Nr5a2 Rat vancomycin multiple interactions ISO Nr5a2 (Mus musculus) 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA CTD PMID:24657338 Nr5a2 Rat vincristine increases expression ISO NR5A2 (Homo sapiens) 6480464 Vincristine results in increased expression of NR5A2 mRNA CTD PMID:23649840
Imported Annotations - KEGG (archival)
(-)-demecolcine (ISO) (1->4)-beta-D-glucan (ISO) 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (EXP) 1,2-dilauroyl-sn-glycero-3-phosphocholine(1+) (ISO) 1-O-oleoyl-sn-glycero-3-phosphocholine (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (EXP,ISO) 17beta-estradiol 3-benzoate (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2-methoxyethanol (EXP) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) 9-cis-retinoic acid (ISO) acetic acid (ISO) aflatoxin B1 (EXP,ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) ammonium chloride (EXP) androst-4-ene-3,17-dione (EXP) arachidonic acid (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) atrazine (ISO) Azoxymethane (ISO) aztreonam (ISO) benzo[a]pyrene (ISO) benzo[e]pyrene (ISO) bis(2-ethylhexyl) phthalate (EXP,ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) bromochloroacetic acid (ISO) bromocriptine (EXP) C60 fullerene (EXP) cadmium atom (ISO) carbon nanotube (ISO) cefalotin (ISO) cholesterol (ISO) choline (ISO) cisplatin (ISO) clofibrate (ISO) cobalt dichloride (EXP,ISO) colforsin daropate hydrochloride (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dexamethasone (EXP) dextran sulfate (ISO) dibenz[a,h]anthracene (ISO) diethylstilbestrol (ISO) Diosbulbin B (ISO) dioxygen (EXP) endosulfan (EXP) flutamide (EXP) folic acid (ISO) formaldehyde (ISO) fulvestrant (ISO) genistein (ISO) gentamycin (EXP) imipenem hydrate (ISO) L-methionine (ISO) lead nitrate (ISO) linoleic acid (ISO) lipopolysaccharide (ISO) lithocholic acid (EXP) lysophosphatidylcholine (ISO) lysophosphatidylethanolamine (ISO) methapyrilene (EXP,ISO) methylmercury chloride (ISO) N-methyl-4-phenylpyridinium (ISO) N-nitrosodiethylamine (EXP) neomycin (ISO) nitrofen (EXP) obeticholic acid (ISO) ozone (ISO) p-toluidine (EXP) paracetamol (EXP,ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) phorbol 13-acetate 12-myristate (ISO) phosphatidylcholine (ISO) pirinixic acid (ISO) potassium dichromate (ISO) pregnenolone 16alpha-carbonitrile (EXP) progesterone (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) sodium arsenite (ISO) succimer (ISO) sulforaphane (EXP) sulpiride (EXP) testosterone (EXP) tetrachloromethane (EXP,ISO) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP,ISO) ursodeoxycholic acid (ISO) valproic acid (ISO) vancomycin (ISO) vincristine (ISO)
Biological Process
acinar cell differentiation (IEA,ISO) bile acid metabolic process (IEA,ISO) calcineurin-mediated signaling (IMP) cartilage development (IEA,ISO) cellular response to leukemia inhibitory factor (IEA,ISO) cholesterol homeostasis (IEA,ISO) chromatin remodeling (IEA,ISO,ISS) embryonic cleavage (IEA,ISO,ISS) exocrine pancreas development (IEA,ISO,ISS) hormone-mediated signaling pathway (IBA) inner cell mass cell differentiation (IEA,ISO) intracellular receptor signaling pathway (IEA) morula formation (IEA,ISO,ISS) negative regulation of chondrocyte differentiation (IEA,ISO,ISS) negative regulation of inflammatory response (IEA,ISO,ISS) neurogenesis (IEA,ISO,ISS) pancreas morphogenesis (IEA,ISO) positive regulation of DNA-templated transcription (IEA,ISO,ISS) positive regulation of glucocorticoid biosynthetic process (IEA,ISO,ISS) positive regulation of stem cell differentiation (IEA,ISO,ISS) positive regulation of T cell activation (IEA,ISO,ISS) positive regulation of T cell anergy (IEA,ISO,ISS) positive regulation of T cell proliferation (IEA,ISO,ISS) positive regulation of tendon cell differentiation (IEA,ISO,ISS) positive regulation of transcription by RNA polymerase II (IEA,ISO) positive regulation of viral genome replication (IEA,ISO) primary ovarian follicle growth (IEA,ISO,ISS) regulation of cell population proliferation (IEA,ISO) regulation of DNA-templated transcription (IEA,ISO,ISS) regulation of transcription by RNA polymerase II (IBA) Sertoli cell development (IEA,ISO,ISS) somatic stem cell population maintenance (IEA,ISO,ISS) spermatogenesis (IEA,ISO,ISS) tissue development (IBA) zygotic genome activation (IEA,ISO,ISS)
Molecular Function
chromatin binding (IEA,ISO) DNA binding (IEA,ISO,ISS) DNA-binding transcription activator activity, RNA polymerase II-specific (IEA,ISO) DNA-binding transcription factor activity (IEA,ISO,ISS) double-stranded DNA binding (IDA) lipid binding (IEA) metal ion binding (IEA) nuclear receptor activity (IDA,IEA,ISO,ISS) phospholipid binding (IEA,ISO) protein binding (ISO) RNA polymerase II cis-regulatory region sequence-specific DNA binding (IBA,IEA,ISO) sequence-specific DNA binding (IEA,ISO) sequence-specific double-stranded DNA binding (IEA,ISO) transcription cis-regulatory region binding (IEA,ISO) transcription coregulator binding (IEA,ISO) zinc ion binding (IEA)
1.
The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family.
Galarneau L, etal., Mol Cell Biol 1996 Jul;16(7):3853-65.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
4.
Calcineurin and CRTC2 mediate FSH and TGFß1 upregulation of Cyp19a1 and Nr5a in ovary granulosa cells.
Lai WA, etal., J Mol Endocrinol. 2014 Oct;53(2):259-70. doi: 10.1530/JME-14-0048. Epub 2014 Jul 23.
5.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
6.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
7.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
8.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
9.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
10.
Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functions.
Schwaderer J, etal., Cell Death Dis. 2017 Apr 13;8(4):e2745. doi: 10.1038/cddis.2017.173.
11.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
Nr5a2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 50,865,253 - 50,985,107 (-) NCBI GRCr8 mRatBN7.2 13 48,313,634 - 48,433,494 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 48,316,301 - 48,433,326 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 50,924,322 - 51,041,371 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 52,212,210 - 52,329,237 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 49,479,256 - 49,596,284 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 53,750,470 - 53,870,288 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 53,750,473 - 53,870,428 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 58,791,496 - 58,910,967 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 49,931,592 - 50,048,756 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 13 49,945,671 - 50,062,836 (-) NCBI Celera 13 48,623,262 - 48,740,634 (-) NCBI Celera Cytogenetic Map 13 q13 NCBI
NR5A2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 200,027,710 - 200,177,415 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 200,027,614 - 200,177,420 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 199,996,838 - 200,146,543 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 198,263,393 - 198,413,175 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 196,728,426 - 196,878,205 NCBI Celera 1 173,119,461 - 173,269,192 (+) NCBI Celera Cytogenetic Map 1 q32.1 NCBI HuRef 1 171,163,369 - 171,312,952 (+) NCBI HuRef CHM1_1 1 201,419,353 - 201,569,071 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 199,284,725 - 199,434,351 (+) NCBI T2T-CHM13v2.0
Nr5a2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 1 136,770,300 - 136,888,186 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 1 136,770,309 - 136,888,186 (-) Ensembl GRCm39 Ensembl GRCm38 1 136,842,562 - 136,960,448 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 1 136,842,571 - 136,960,448 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 1 138,740,161 - 138,857,025 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 1 138,660,687 - 138,776,859 (-) NCBI MGSCv36 mm8 Celera 1 139,488,247 - 139,612,651 (-) NCBI Celera Cytogenetic Map 1 E4 NCBI cM Map 1 59.98 NCBI
Nr5a2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955406 36,263,184 - 36,415,525 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955406 36,263,257 - 36,415,494 (+) NCBI ChiLan1.0 ChiLan1.0
NR5A2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 49,206,752 - 49,357,599 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 49,168,065 - 49,318,860 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 175,625,140 - 175,775,955 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 179,934,573 - 180,083,607 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 179,934,573 - 180,083,607 (+) Ensembl panpan1.1 panPan2
NR5A2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 2,925,915 - 3,062,118 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 2,927,326 - 3,062,348 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 2,609,186 - 2,746,673 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 2,572,723 - 2,710,945 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 2,575,836 - 2,711,009 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 2,555,273 - 2,692,729 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 2,656,611 - 2,794,291 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 2,688,192 - 2,825,725 (-) NCBI UU_Cfam_GSD_1.0
Nr5a2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 74,848,490 - 74,960,157 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936567 4,084,608 - 4,212,854 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936567 4,084,161 - 4,194,858 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NR5A2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 10 22,715,735 - 22,865,364 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 10 22,727,865 - 22,866,905 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 10 27,281,190 - 27,424,774 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LOC103230356 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 25 29,230,358 - 29,380,617 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 25 29,233,558 - 29,379,922 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666055 30,239,494 - 30,260,729 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Nr5a2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 351 Count of miRNA genes: 203 Interacting mature miRNAs: 233 Transcripts: ENSRNOT00000000812 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1298066 Bp159 Blood pressure QTL 159 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 46088046 91088046 Rat 10755495 Bp387 Blood pressure QTL 387 3.78 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34663461 87525369 Rat 9589141 Insul28 Insulin level QTL 28 10.82 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 13 9313465 54313465 Rat 6893344 Cm79 Cardiac mass QTL 79 1.5 0.04 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 43720770 62022792 Rat 70220 Bp55 Blood pressure QTL 55 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 71119 Thym2 Thymus enlargement QTL 2 3.8 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 13 46197976 84753113 Rat 61391 Bp5 Blood pressure QTL 5 5.6 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 22301875 67301875 Rat 4889861 Pur29 Proteinuria QTL 29 13.8 0.005 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 13 37415584 80753406 Rat 2317040 Aia21 Adjuvant induced arthritis QTL 21 2.75 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 631645 Bp121 Blood pressure QTL 121 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 14915655 59915655 Rat 2317046 Aia8 Adjuvant induced arthritis QTL 8 3.9700000286102295 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 12879441 Bp396 Blood pressure QTL 396 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 45699983 90699983 Rat 619615 Bp80 Blood pressure QTL 80 0.0354 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 39754544 84754544 Rat 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 8897350 101631289 Rat 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 0.0024 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 23203448 68203448 Rat 1331784 Bp222 Blood pressure QTL 222 2.944 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 17694436 53050594 Rat 61340 Bp25 Blood pressure QTL 25 4.2 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34535218 79535218 Rat 1581573 Uae36 Urinary albumin excretion QTL 36 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 1549897 Stresp12 Stress response QTL 12 3.35 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 13 38433408 83433408 Rat 7207885 Glom27 Glomerulus QTL 27 3.9 kidney glomerulus integrity trait (VT:0010546) kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139) 13 20605871 101339738 Rat 1558644 Cm45 Cardiac mass QTL 45 3.6 0.002 heart mass (VT:0007028) heart wet weight (CMO:0000069) 13 23692969 68692969 Rat 70181 BpQTLcluster11 Blood pressure QTL cluster 11 6.922 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 13 31241331 93395974 Rat 61349 Bp31 Blood pressure QTL 31 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 2303563 Bw89 Body weight QTL 89 6 body mass (VT:0001259) body weight (CMO:0000012) 13 32284471 77284471 Rat 1354621 Rf47 Renal function QTL 47 3.7 kidney renin amount (VT:0010559) kidney renin level (CMO:0002166) 13 30395351 101056920 Rat 2301962 Cm72 Cardiac mass QTL 72 4.12 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 13 31241331 58363171 Rat 1581554 Pur11 Proteinuria QTL 11 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 12879477 Bp401 Blood pressure QTL 401 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 37262092 82262092 Rat 1331750 Bp220 Blood pressure QTL 220 2.98 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 37415584 82415584 Rat 6893338 Cm76 Cardiac mass QTL 76 0 0.99 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 23692969 68692969 Rat 1354666 Bp244 Blood pressure QTL 244 4.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 1 101056920 Rat 9589164 Gluco66 Glucose level QTL 66 6.67 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 13 15158722 60158722 Rat 7411662 Foco29 Food consumption QTL 29 20.8 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 13 9313465 54313465 Rat
D13Rat154
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 48,414,651 - 48,414,900 (+) MAPPER mRatBN7.2 Rnor_6.0 13 53,851,498 - 53,851,746 NCBI Rnor6.0 Rnor_5.0 13 58,892,524 - 58,892,772 UniSTS Rnor5.0 RGSC_v3.4 13 50,029,937 - 50,030,186 RGD RGSC3.4 RGSC_v3.4 13 50,029,938 - 50,030,186 UniSTS RGSC3.4 RGSC_v3.1 13 50,044,017 - 50,044,266 RGD Celera 13 48,722,170 - 48,722,418 UniSTS FHH x ACI Map 13 20.43 RGD FHH x ACI Map 13 20.43 UniSTS Cytogenetic Map 13 q13 UniSTS
RH143570
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 48,422,566 - 48,422,735 (+) MAPPER mRatBN7.2 Rnor_6.0 13 53,859,413 - 53,859,581 NCBI Rnor6.0 Rnor_5.0 13 58,900,439 - 58,900,607 UniSTS Rnor5.0 RGSC_v3.4 13 50,037,853 - 50,038,021 UniSTS RGSC3.4 Celera 13 48,730,085 - 48,730,253 UniSTS RH 3.4 Map 13 148.8 UniSTS Cytogenetic Map 13 q13 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
8
39
107
91
90
59
25
59
6
205
85
87
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000000812 ⟹ ENSRNOP00000000812
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 48,316,301 - 48,433,326 (-) Ensembl Rnor_6.0 Ensembl 13 53,750,473 - 53,870,428 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000097279 ⟹ ENSRNOP00000096873
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 48,316,301 - 48,433,326 (-) Ensembl
RefSeq Acc Id:
NM_021742 ⟹ NP_068510
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 50,867,920 - 50,984,938 (-) NCBI mRatBN7.2 13 48,316,301 - 48,433,326 (-) NCBI Rnor_6.0 13 53,753,137 - 53,870,116 (-) NCBI Rnor_5.0 13 58,791,496 - 58,910,967 (-) NCBI RGSC_v3.4 13 49,931,592 - 50,048,756 (-) RGD Celera 13 48,623,262 - 48,740,634 (-) RGD
Sequence:
CCCAGGTCACAAAATATGACAGGCTGCAACCTTCCCCACGTTCAATGATTTCTGCAGTAAGCCAAAGGACTGCCAATAATTTCGCTAAGAATGTCTGCTAGTTCGATTACTGGGGATTTTCAAGACTT TCTTAAGCATGGACTTCCAGCTATTGCACCTGCACCAGGATCAGAGACTCCACACTCCCCCAAACTTGAGGAAAAACACCGGGAAAAACGTGCTGGGCTTCCGGACCGACACCGACGGCCCATTCCCG CCCGCAGCCGCCTTGTCATGCTGCCCAAAGTGGAGACGGAAGCCTCAGGACTGGTCCGATCGCATGGGGAACAGGGGCAGATGCCGGAAAACATGCAAGTGTCTCAATTTAAAATGGTGAATTACTCC TATGATGAAGATCTGGAAGAGCTGTGTCCTGTGTGTGGCGATAAAGTATCTGGGTATCATTACGGTCTCCTCACCTGTGAAAGCTGCAAGGGTTTCTTTAAGCGAACAGTCCAAAACCAGAAAAGGTA CACGTGCATAGAGAACCAGAACTGCCAAATTGACAAGACACAGAGAAAACGATGTCCTTACTGTCGGTTCAAAAAATGTATCGACGTTGGAATGAAGCTGGAGGCCGTGAGAGCTGACCGCATGCGAG GAGGCAGAAATAAGTTCGGGCCAATGTACAAGAGAGACAGGGCCTTGAAACAGCAGAAGAAAGCCCTCATTCGAGCCAATGGACTTAAGCTGGAAGCCATGTCTCAGGTGATCCAAGCGATGCCCTCA GACCTGACCTCTGCAATTCAGAACATTCATTCTGCCTCCAAAGGCCTACCTCTGAGCCATGTAGCCTTGCCTCCGACAGACTATGACAGAAGTCCCTTTGTCACTTCTCCCATTAGCATGACAATGCC ACCTCATGGCAGTCTGCATGGTTACCAACCATATGGTCACTTTCCTAATCGGGCCATCAAGTCTGAGTACCCAGACCCCTACTCCAGCTCGCCAGAGTCAATGATGGGCTACTCCTACATGGATGGTT ACCAGACAAGCTCCCCGGCAAGCATCCCTCATCTGATATTGGAACTTTTGAAGTGTGAACCCGATGAGCCTCAAGTTCAAGCGAAAATCATGGCTTACCTACAGCAAGAGCAGAATAACCGGAACAGG CAGGAAAAGCTGAGCGCGTTTGGGCTCTTGTGCAAAATGGCGGACCAGACCCTGTTCTCCATTGTTGAGTGGGCCAGGAGTAGTATCTTCTTCAGGGAACTGAAGGTTGATGACCAAATGAAGCTGCT TCAGAACTGCTGGAGTGAGCTCTTGATCCTGGATCACATTTACCGGCAAGTAGCACATGGGAAGGAAGGGACAATCTTCCTGGTTACCGGAGAACACGTGGACTACTCCAGCATCATCTCAAACACAG AAGTCGCATTCAACAACCTCCTGAGCCTCGCCCAGGAGCTCGTGGTGAGACTCCGTTCCCTTCAGTTTGATCAGCGGGAGTTTGTGTGTCTGAAGTTCCTGGTGCTGTTCAGCTCAGATGTCAAGAAT CTTGAGAACTTCCAGCTGGTGGAAGGCGTCCAAGAGCAGGTCAATGCTGCCCTGCTGGACTACACACTTTGCAACTACCCACAACAAACTGAGAAATTTGGACAACTGCTTCTTCGACTACCAGAAAT CCGGGCAATCAGCAAACAGGCAGAAGACTACCTGTACTACAAGCACGTGAATGGGGATGTGCCCTACAATAACCTTCTCATTGAAATGCTGCACGCCAAAAGAGCCTAAGTTCCCACCCCTAGACCCT TGCTCTAGGGACAGAGACTGGAGGGAGAAGAAGAGGAGGAGGAGGAAGGAAGACAAACAATGCTCTGAACTGCTCCAAGCAATGCTAATTACAAACTTGGTTTAAAGACACTGAATTTTGAAAGCATA ATAATGAATAG
hide sequence
RefSeq Acc Id:
XM_006249928 ⟹ XP_006249990
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 50,865,253 - 50,985,107 (-) NCBI mRatBN7.2 13 48,313,634 - 48,433,494 (-) NCBI Rnor_6.0 13 53,750,470 - 53,870,288 (-) NCBI Rnor_5.0 13 58,791,496 - 58,910,967 (-) NCBI
Sequence:
TTAGAAACCATCATGAAACTGGAGCCATGGTTTACAGCAGGTCACGAATGCTGGAAAAAGTACA GAGTCCAGGAGAGCATGGCTTGGGCCTTTCTGAATTCTGTTTTTTTCCCCCTTTTTTTCTTAACTTTCACTAAGGAGATGAGGGTTACGGTAGTCTGAGGCTTCCTTCCCCAGGTCACAAAATATGAC AGGCTGCAACCTTCCCCACGTTCAATGATTTCTGCAGTAAGCCAAAGGACTGCCAATAATTTCGCTAAGAATGTCTGCTAGTTCGATTACTGGGGATTTTCAAGACTTTCTTAAGCATGGACTTCCAG CTATTGGTGCTGGGCTTCCGGACCGACACCGACGCCCCATTCCCGCCCGCAGCCGCCTTGTCATGCTGCCCAAAGTGGAGACGGAAGCCTCAGGACTGGTCCGATCGCATGGGGAACAGGGGCAGATG CCGGAAAACATGCAAGTGTCTCAATTTAAAATGGTGAATTACTCCTATGATGAAGATCTGGAAGAGCTGTGTCCTGTGTGTGGCGATAAAGTATCTGGGTATCATTACGGTCTCCTCACCTGTGAAAG CTGCAAGGGTTTCTTTAAGCGAACAGTCCAAAACCAGAAAAGGTACACGTGCATAGAGAACCAGAACTGCCAAATTGACAAGACACAGAGAAAACGATGTCCTTACTGTCGGTTCAAAAAATGTATCG ACGTTGGAATGAAGCTGGAGGCCGTGAGAGCTGACCGCATGCGAGGAGGCAGAAATAAGTTCGGGCCAATGTACAAGAGAGACAGGGCCTTGAAACAGCAGAAGAAAGCCCTCATTCGAGCCAATGGA CTTAAGCTGGAAGCCATGTCTCAGGTGATCCAAGCGATGCCCTCAGACCTGACCTCTGCAATTCAGAACATTCATTCTGCCTCCAAAGGCCTACCTCTGAGCCATGTAGCCTTGCCTCCGACAGACTA TGACAGAAGTCCCTTTGTCACTTCTCCCATTAGCATGACAATGCCACCTCATGGCAGTCTGCATGGTTACCAACCATATGGTCACTTTCCTAATCGGGCCATCAAGTCTGAGTACCCAGACCCCTACT CCAGCTCGCCAGAGTCAATGATGGGCTACTCCTACATGGATGGTTACCAGACAAGCTCCCCGGCAAGCATCCCTCATCTGATATTGGAACTTTTGAAGTGTGAACCCGATGAGCCTCAAGTTCAAGCG AAAATCATGGCTTACCTACAGCAAGAGCAGAATAACCGGAACAGGCAGGAAAAGCTGAGCGCGTTTGGGCTCTTGTGCAAAATGGCGGACCAGACCCTGTTCTCCATTGTTGAGTGGGCCAGGAGTAG TATCTTCTTCAGGGAACTGAAGGTTGATGACCAAATGAAGCTGCTTCAGAACTGCTGGAGTGAGCTCTTGATCCTGGATCACATTTACCGGCAAGTAGCACATGGGAAGGAAGGGACAATCTTCCTGG TTACCGGAGAACACGTGGACTACTCCAGCATCATCTCAAACACAGAAGTCGCATTCAACAACCTCCTGAGCCTCGCCCAGGAGCTCGTGGTGAGACTCCGTTCCCTTCAGTTTGATCAGCGGGAGTTT GTGTGTCTGAAGTTCCTGGTGCTGTTCAGCTCAGATGTCAAGAATCTTGAGAACTTCCAGCTGGTGGAAGGCGTCCAAGAGCAGGTCAATGCTGCCCTGCTGGACTACACACTTTGCAACTACCCACA ACAAACTGAGAAATTTGGACAACTGCTTCTTCGACTACCAGAAATCCGGGCAATCAGCAAACAGGCAGAAGACTACCTGTACTACAAGCACGTGAATGGGGATGTGCCCTACAATAACCTTCTCATTG AAATGCTGCACGCCAAAAGAGCCTAAGTTCCCACCCCTAGACCCTTGCTCTAGGGACAGAGACTGGAGGGAGAAGAAGAGGAGGAGGAGGAAGGAAGACAAACAATGCTCTGAACTGCTCCAAGCAAT GCTAATTACAAACTTGGTTTAAAGACACTGAATTTTGAAAGCATAATAATGAATAGCAAATAAATGATATATCAGGGTATTTGTACTGTAAACTGTGAATCAAAGGCTGCATATCCCCAAAGGATTCA TAATGGGATGGATTGAACTTACAGGTGGAGACCAATACCACAGCAGAATGAAAATGGACGAAACAATCCTTGTATATTTAAACTAATCTTCTATTAAGAAATTCAGCAATTGATCTGTGTTATTAATT GGACTTGTCCAGAATTACTCCATGGTGAAGCTGAACAACTCAAGAATACATGGGCTGAGCCCCGGCAGCCCCTCCATCCCCCCAGAAGGCCCTATGCCTTCTGACCTGTGAGCCCTGAAGCTATGTTA AGGACTTGTATTCAGCCACACCCAGTAGTAGCTCCACTAAACCATGATTTCTGAATGTCTGTGTCTTAGACCTGCCAACAGCTAATAAGAACAATATATAAATATGTCAGCTTGCCGTTTTAAATATG TTCTGAAGTTTGTTTTGTCGTGTGTTTGTAATTAAAAAAAAAAAAACAGGCAGTATCCCTCTTCTATATAAACATTACTTAATATTAAGGGAAATCAAACAAATCTAAGCCAATACTCCCAACAAGCA AGTTAGATCTTGTTTCTGCTGTTGTTGTTGAAATGTGGCTTTGGCATGGTTTCATAAAAATTTTTGGCCAAGAGGCTTATGTTAGTATACATCCATCTGTTTAGTCATCAAGGTTTGTAGTTCACTCA AAAATAAACCACTAGACATCTTTTGCTGGATGTCAAATAGTCACAGTCTAAGTAGCTGGAAAGTCAAAGCAGTTTGAGCATTGCCAAATGAAAGAATGGTTGGGCTGCAAAGATGATTGACTCAAGCA AGGTTCATCCCAGTTGTAACTTGAGCATCCCCTAAACTGGGGATGCAAAAGCGTATGGCCTGGGAAGACAGGAAAGCCAGTCCTCCTACAAAGGGGAAGTGGAAGATACTGGCCTCTCATAGTCATAG ACCAAAGTCTGCTATAGAACAAAATACTGGAGGGCAGAGATAGCAAACAAAGTCTCCAAACAGTGCTGTCAGTATTAGCATGCGATGCCACAGGCATGGAAACCTTGCCTTACTTCCTGGTCCTGAAA GGGAACTGTGCAGATGTGGATCAACGTTTTGTTGAAAATAAAGTATTAATACTTTAAAGTCAAAATATAGTGTTTACATTCTTTAGGTCCTGGGAGGAGCTGGGGGGAGGGACTCTTGATAATACAAG ATAGTAGAAGCAGTCGTTTCTTTAATTATTTTTAACAGTTTAATTATTGTATGTCGTGAGACACTAAAATCAAGAATGGGACTCTCATTTCCTCTATAATTTGTTAAGATTACCAGCAGCACAATCAC TTGTAGAAACTGTATTAAAAAAAAAAATCTCCCAGTCCCTTTGTTTCTGGCTTTGGAATAGTTTTATTTATATTGTATATCATAATAGTTTCAACTATAGACAATTACAATGTTAATTTATTGTTCCT TGGGTTCCCCTTTGTATAAGATAGAGCCAAGACTAAAGAAACCAAATATATGTGTTTACTATAGCATGTCTTCAAGTTAGTGAAACATAGTTCAGGGGTATAGAAGGGTCTTAATGATTAAAACCATC CATTTGATCACATGTCCTGAAATTCCCATAATCTTTCTGTATCTTATTTAATATCCATTGTAAATCATGTGACTTAATAGCTTTTTCTTGTTTTTAAGACATTTTAACAATAAAAAGAGTCTTGCCTG GTTTTCCTTTCCAAACATTGTAAGTTGTATACCAAAGATATTAGTTTATTACTTCAGTGTGTTTTTTAAAAAAAGATTATTTTATTACATTTATGAATCGCCTGTAATATCCACCCACGGGAGGGACT CACACTAGCTGTGTTGGGATTGACTCTCAGTGTTATCCTCGTTACTCTAAGGAGGAGGAAAGTCATTAATGAAAGCTCAGATCCAAAGCATTAAACCAGACAGAGATATGGCTGTTCCTCCCACTGAA AAACCCAAGTTGGTTAAAGGCACACGGAGAAGGTGCAGATGCCAGTGGCTAATGGGAGAGCTCTATCTTGGGTGTCAATGTGACTAGAAGGATGGCTGTTTGGAGGGTTTTGACATTGAAGACAAAAA ATCCATGTTTCCCTATTTTACATATCTAGTGCTCCCCTACCCAACATTAAACCTAAAAGTTGTCAAATACTGGTTTGTCGTTCACCGAGTAGCTTTCACCCTGAGAATGGTTAGAGAAACAGGCAACA GTCACATCCATACCAAGGACAGAAGCAGCTTGAGCAGGAGTGTAGGTGGTGCCCTGCAGTTATCGGATGTCAGTTGGTAGCCCAGTTTGTAACTTAGCCAACTGCTTTATTGATTTCTAGGGTTCCTA ATAAAGGCAGACTCAAGAGGGAAAGGTCTTCAACTGAGCTGGGTTTCCCGTAGTTGGTCTCTGTGAAGAGACAGTCTGTGATGTCTTGAGTCTTTGGATGGTGGCTCTTCCGCAGCTGCCTTGGACTT GAATCCATGCAGTCTTCAGAGTGTAGAGTTGGTACCTTGTTGACGTCTTCTTACTGTATCAGTGAAATATACACATTGTCATGTCGGTTCTTGCCATGAATTTCTCAATGAAAGTGGATTTTTTTCCA GTATTTCAATAAATATTGATATGTCCACCTGGTAA
hide sequence
RefSeq Acc Id:
XM_006249929 ⟹ XP_006249991
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 50,865,253 - 50,971,618 (-) NCBI mRatBN7.2 13 48,313,634 - 48,420,018 (-) NCBI Rnor_6.0 13 53,750,470 - 53,859,245 (-) NCBI Rnor_5.0 13 58,791,496 - 58,910,967 (-) NCBI
Sequence:
GTGGCTCGGCGCTCCGGCTCTTGGCTTTTACACCCTCAGGCTAACCCCGCGCGCTTCAGCCTCC TGCAGCATGGGCACTAGAGCAGCCCGGCCGGCAGTTTGCGATTCGCCGGCTTCGGCCTCCTCTCTAGACTCGAGCATAAAAGTTAATGGCACTTGAACTAGGCGGACGGTGCTTTCTCATCAACGTCT AATTGGCCACTTCTAATTAAGTAGAGAGACTTGAAGCTCAGAGCCAACTGGAGCTGTGGCAGCTAGAAGATAAGGGTGCCGTGGAATTATCTTTCTGAGGAACGGAATTCCTCTTTGCTCACAGGTTC TAGGTTGTTCGAGCTCTTAACGCACATGCTCCCGTGTGGAGGGAAGAGACTGACTAGAATAGCAGAGTATATACAAGAGAAGATCACAAGGAAGGCGATTGGTGGTGTTAGTGGTGTTCGATTGCACG AGCACCCCCAAAAAGCCTTGCCGGACCCGGCAGTCTTTTAAGGCAACTCAAAACTGCTGGCATAGCAAAAAATACCAATTACCCCAACTCTATTCCCTTCCAGGATAATGCGAAATGAGGAGTTTGGT CATTGCCCTTTCGGTCTCAGAGCCTTGGGTCTCAAAGCCGTGAGTGTGGGCATTCCATATATGTCCCCATTCTTGATTGGTAACATCAGAAAAAGACCAAAACCCCATCTCCTGTATTTTCTATACTC AAAACTCTTAAGAACTTTATTTTAGCTACGGGCCAAGGTGGAAACAATGCAAGGAAAAGTTTTTCTATCTTCGGCCATACCAGAGTTCAAGATGTTGAGGCCAGCCGGCTTGTGATTCTCCCCCCAAA ATTTCCTGCCGTCCTTGTGCGCAAACTTGAAAGGGTCAGAGGAGTGCTGAGAACTGAGAGCTCTTACACTCTATGGTGCTTGGTAGGCTGCGCTCCTAGCCCGGGAAACCTAAGGTCACCTTAGGCTC CAGGAAAGGGGTCGGCAGGCATGCGGGTGGGGTCAGATATCCTGGGTGATCTTGGGGTCTTTCCAAGTCCTTGGGTAGGGTTGTAAAGTTTACTGGCTTCTGTCCCCAGACTAACTTAGCATGTCTGC TGGGGAGGAAGCCTTATTGGCCTAAGAGGTGTACCTGGAATTCCTGAGAAGTGCCCCAGGCCTGCTTCCTGCGATCTGGCCTCGGGCACTAAGTTTCCTCCCACGCAGGAGGACCGGCTTTTTCCTAC TTCCTGCCCCATACAGACATTTAGGGTGACAGGATCCGGGAAAAACAGCGCAGCGGAGCGAAACACAATGTACTGAGGACTGGAGAGAAATAACGCGGGTAGCGTTTTCTTTGTAAAATTGAGAGGAC CCTTTGGCTTCCTGACCACAAGCCATTAGCTTGCCTTTTGCTGGGGGGCTAGCGGTACGGCCCTAGGTAGCTTGGCACTGAGCTCGAAAGCAGCACGGGAATGAGCCTGGCGCGGCTTTGCGGTAGTT TGCGTCCTGAACCGAGCACACCTGCCTGCCCACTGTAGGCTCCCTCACCAGGGATATATTCATACTTTGACGGATGCTGGAACCCAGAAAGAAAATTCGTTACTGGATTCTCAGGCAGCGCGAAGCAT CCAATTTAGAGGGGATTAACGGAGGACAGCTTTTCAAGACCCGGTTGTTTCCTCTGGCAGGGGATTTCCAAACCATGGTGGATTTGGGCCTCCGAAATCATAATTTAGGTGCCCCAGGTGCTCTGTGA GTAGACAAAAAATGATTCTCTGGCCTCACAGATGCACCTCTCCGGATTTTACCGGAAGATGGGCTTCTGTGTTTCCTTCTATATGGCATCTCTGAGATGCGTACGGAGAGTGTAGTGGTTGCCAATCT GAAACTCTTAAATGTGAAGTTAGGTTACTTTTGGGGGAGACAGGGAGACAGAAGAGAACACGCATTTAATAAAAAGTACAGCCCGGCTCAACCCAGAAACATACCTAGAAACAGAAGTCACGAGTTTT CAGAGTTCCGTAAACAAACTCCCCCAACCCAAAGCTTTCCCCAAACCCCCAGGTTCTGATTGTTTAGAGTGTCTCAGCCTCTCTCTCTAGTAGTTGGGGTACAAGCTGGCTTCGCCGGAAAGAGGTGC GCTCAGCATCCCTTATTTCTGAGTTACTGAGCCCCGGGAATACATTGCTGGCGTCTCTTCCCAAAATCTTTGCAAACTGTTGCTCTCAGACCAACTTACGCTGCAGCCCACAGCTCTGTGTCCCGGAG CAGACACCTCATTAAGAGATTGAGAAATTAAAAAAAAAAAAGAACTTCATTTTAAAAGAATAAAGATATCACCTGGGTGATAAAGAGGCATAGTACTTTGGCTCTGTGGTAGGGGCAGTTTCTCCATT TTCTTTTTAGTAAACAAATCTGAGGAAACTTCTGCCAGGCTGTGGGTACCCCTCCCCCGCCCCGCCCCTTGCAATGCCACTGATTAACTTAAAGCAAACTGTCTTTGGAGTTTGTGCGTCTTTGGGTA GCAGAGGGTTGAGCAAGGGGGCCCGGAGCCGGGTGCACAAAGGGTTTAAAGAGGGTGCGGATGCCGCCCCACCCCTGCTCTGCCTCCTGCTTGGAAATAGGGGTGGGTGGGTGGTCGCTGAAGTGGGT TTTCAGTCTCATCAGATAGTGCCTAGGGGGGGTCTGTTGGCCACTGACCTTTACATGCACAATTTATCTTTTTGGCTGCAAAGACTAGGGCGTCAGTGGCCCTAGTCATAGTCAGGATACCATGGTCT GATTTTGTTCAACCGGCAATCTCAGAGGTGTTTATACTTTTAAGTGTCTCAATTTAAAATGGTGAATTACTCCTATGATGAAGATCTGGAAGAGCTGTGTCCTGTGTGTGGCGATAAAGTATCTGGGT ATCATTACGGTCTCCTCACCTGTGAAAGCTGCAAGGGTTTCTTTAAGCGAACAGTCCAAAACCAGAAAAGGTACACGTGCATAGAGAACCAGAACTGCCAAATTGACAAGACACAGAGAAAACGATGT CCTTACTGTCGGTTCAAAAAATGTATCGACGTTGGAATGAAGCTGGAGGCCGTGAGAGCTGACCGCATGCGAGGAGGCAGAAATAAGTTCGGGCCAATGTACAAGAGAGACAGGGCCTTGAAACAGCA GAAGAAAGCCCTCATTCGAGCCAATGGACTTAAGCTGGAAGCCATGTCTCAGGTGATCCAAGCGATGCCCTCAGACCTGACCTCTGCAATTCAGAACATTCATTCTGCCTCCAAAGGCCTACCTCTGA GCCATGTAGCCTTGCCTCCGACAGACTATGACAGAAGTCCCTTTGTCACTTCTCCCATTAGCATGACAATGCCACCTCATGGCAGTCTGCATGGTTACCAACCATATGGTCACTTTCCTAATCGGGCC ATCAAGTCTGAGTACCCAGACCCCTACTCCAGCTCGCCAGAGTCAATGATGGGCTACTCCTACATGGATGGTTACCAGACAAGCTCCCCGGCAAGCATCCCTCATCTGATATTGGAACTTTTGAAGTG TGAACCCGATGAGCCTCAAGTTCAAGCGAAAATCATGGCTTACCTACAGCAAGAGCAGAATAACCGGAACAGGCAGGAAAAGCTGAGCGCGTTTGGGCTCTTGTGCAAAATGGCGGACCAGACCCTGT TCTCCATTGTTGAGTGGGCCAGGAGTAGTATCTTCTTCAGGGAACTGAAGGTTGATGACCAAATGAAGCTGCTTCAGAACTGCTGGAGTGAGCTCTTGATCCTGGATCACATTTACCGGCAAGTAGCA CATGGGAAGGAAGGGACAATCTTCCTGGTTACCGGAGAACACGTGGACTACTCCAGCATCATCTCAAACACAGAAGTCGCATTCAACAACCTCCTGAGCCTCGCCCAGGAGCTCGTGGTGAGACTCCG TTCCCTTCAGTTTGATCAGCGGGAGTTTGTGTGTCTGAAGTTCCTGGTGCTGTTCAGCTCAGATGTCAAGAATCTTGAGAACTTCCAGCTGGTGGAAGGCGTCCAAGAGCAGGTCAATGCTGCCCTGC TGGACTACACACTTTGCAACTACCCACAACAAACTGAGAAATTTGGACAACTGCTTCTTCGACTACCAGAAATCCGGGCAATCAGCAAACAGGCAGAAGACTACCTGTACTACAAGCACGTGAATGGG GATGTGCCCTACAATAACCTTCTCATTGAAATGCTGCACGCCAAAAGAGCCTAAGTTCCCACCCCTAGACCCTTGCTCTAGGGACAGAGACTGGAGGGAGAAGAAGAGGAGGAGGAGGAAGGAAGACA AACAATGCTCTGAACTGCTCCAAGCAATGCTAATTACAAACTTGGTTTAAAGACACTGAATTTTGAAAGCATAATAATGAATAGCAAATAAATGATATATCAGGGTATTTGTACTGTAAACTGTGAAT CAAAGGCTGCATATCCCCAAAGGATTCATAATGGGATGGATTGAACTTACAGGTGGAGACCAATACCACAGCAGAATGAAAATGGACGAAACAATCCTTGTATATTTAAACTAATCTTCTATTAAGAA ATTCAGCAATTGATCTGTGTTATTAATTGGACTTGTCCAGAATTACTCCATGGTGAAGCTGAACAACTCAAGAATACATGGGCTGAGCCCCGGCAGCCCCTCCATCCCCCCAGAAGGCCCTATGCCTT CTGACCTGTGAGCCCTGAAGCTATGTTAAGGACTTGTATTCAGCCACACCCAGTAGTAGCTCCACTAAACCATGATTTCTGAATGTCTGTGTCTTAGACCTGCCAACAGCTAATAAGAACAATATATA AATATGTCAGCTTGCCGTTTTAAATATGTTCTGAAGTTTGTTTTGTCGTGTGTTTGTAATTAAAAAAAAAAAAACAGGCAGTATCCCTCTTCTATATAAACATTACTTAATATTAAGGGAAATCAAAC AAATCTAAGCCAATACTCCCAACAAGCAAGTTAGATCTTGTTTCTGCTGTTGTTGTTGAAATGTGGCTTTGGCATGGTTTCATAAAAATTTTTGGCCAAGAGGCTTATGTTAGTATACATCCATCTGT TTAGTCATCAAGGTTTGTAGTTCACTCAAAAATAAACCACTAGACATCTTTTGCTGGATGTCAAATAGTCACAGTCTAAGTAGCTGGAAAGTCAAAGCAGTTTGAGCATTGCCAAATGAAAGAATGGT TGGGCTGCAAAGATGATTGACTCAAGCAAGGTTCATCCCAGTTGTAACTTGAGCATCCCCTAAACTGGGGATGCAAAAGCGTATGGCCTGGGAAGACAGGAAAGCCAGTCCTCCTACAAAGGGGAAGT GGAAGATACTGGCCTCTCATAGTCATAGACCAAAGTCTGCTATAGAACAAAATACTGGAGGGCAGAGATAGCAAACAAAGTCTCCAAACAGTGCTGTCAGTATTAGCATGCGATGCCACAGGCATGGA AACCTTGCCTTACTTCCTGGTCCTGAAAGGGAACTGTGCAGATGTGGATCAACGTTTTGTTGAAAATAAAGTATTAATACTTTAAAGTCAAAATATAGTGTTTACATTCTTTAGGTCCTGGGAGGAGC TGGGGGGAGGGACTCTTGATAATACAAGATAGTAGAAGCAGTCGTTTCTTTAATTATTTTTAACAGTTTAATTATTGTATGTCGTGAGACACTAAAATCAAGAATGGGACTCTCATTTCCTCTATAAT TTGTTAAGATTACCAGCAGCACAATCACTTGTAGAAACTGTATTAAAAAAAAAAATCTCCCAGTCCCTTTGTTTCTGGCTTTGGAATAGTTTTATTTATATTGTATATCATAATAGTTTCAACTATAG ACAATTACAATGTTAATTTATTGTTCCTTGGGTTCCCCTTTGTATAAGATAGAGCCAAGACTAAAGAAACCAAATATATGTGTTTACTATAGCATGTCTTCAAGTTAGTGAAACATAGTTCAGGGGTA TAGAAGGGTCTTAATGATTAAAACCATCCATTTGATCACATGTCCTGAAATTCCCATAATCTTTCTGTATCTTATTTAATATCCATTGTAAATCATGTGACTTAATAGCTTTTTCTTGTTTTTAAGAC ATTTTAACAATAAAAAGAGTCTTGCCTGGTTTTCCTTTCCAAACATTGTAAGTTGTATACCAAAGATATTAGTTTATTACTTCAGTGTGTTTTTTAAAAAAAGATTATTTTATTACATTTATGAATCG CCTGTAATATCCACCCACGGGAGGGACTCACACTAGCTGTGTTGGGATTGACTCTCAGTGTTATCCTCGTTACTCTAAGGAGGAGGAAAGTCATTAATGAAAGCTCAGATCCAAAGCATTAAACCAGA CAGAGATATGGCTGTTCCTCCCACTGAAAAACCCAAGTTGGTTAAAGGCACACGGAGAAGGTGCAGATGCCAGTGGCTAATGGGAGAGCTCTATCTTGGGTGTCAATGTGACTAGAAGGATGGCTGTT TGGAGGGTTTTGACATTGAAGACAAAAAATCCATGTTTCCCTATTTTACATATCTAGTGCTCCCCTACCCAACATTAAACCTAAAAGTTGTCAAATACTGGTTTGTCGTTCACCGAGTAGCTTTCACC CTGAGAATGGTTAGAGAAACAGGCAACAGTCACATCCATACCAAGGACAGAAGCAGCTTGAGCAGGAGTGTAGGTGGTGCCCTGCAGTTATCGGATGTCAGTTGGTAGCCCAGTTTGTAACTTAGCCA ACTGCTTTATTGATTTCTAGGGTTCCTAATAAAGGCAGACTCAAGAGGGAAAGGTCTTCAACTGAGCTGGGTTTCCCGTAGTTGGTCTCTGTGAAGAGACAGTCTGTGATGTCTTGAGTCTTTGGATG GTGGCTCTTCCGCAGCTGCCTTGGACTTGAATCCATGCAGTCTTCAGAGTGTAGAGTTGGTACCTTGTTGACGTCTTCTTACTGTATCAGTGAAATATACACATTGTCATGTCGGTTCTTGCCATGAA TTTCTCAATGAAAGTGGATTTTTTTCCAGTATTTCAATAAATATTGATATGTCCACCTGGTAA
hide sequence
RefSeq Acc Id:
NP_068510 ⟸ NM_021742
- UniProtKB:
Q9QWM0 (UniProtKB/Swiss-Prot), Q9QWM1 (UniProtKB/Swiss-Prot)
- Sequence:
MSASSITGDFQDFLKHGLPAIAPAPGSETPHSPKLEEKHREKRAGLPDRHRRPIPARSRLVMLPKVETEASGLVRSHGEQGQMPENMQVSQFKMVNYSYDEDLEELCPVCGDKVSGYHYGLLTCESCK GFFKRTVQNQKRYTCIENQNCQIDKTQRKRCPYCRFKKCIDVGMKLEAVRADRMRGGRNKFGPMYKRDRALKQQKKALIRANGLKLEAMSQVIQAMPSDLTSAIQNIHSASKGLPLSHVALPPTDYDR SPFVTSPISMTMPPHGSLHGYQPYGHFPNRAIKSEYPDPYSSSPESMMGYSYMDGYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQNNRNRQEKLSAFGLLCKMADQTLFSIVEWARSSIF FRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHVDYSSIISNTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFSSDVKNLENFQLVEGVQEQVNAALLDYTLCNYPQQT EKFGQLLLRLPEIRAISKQAEDYLYYKHVNGDVPYNNLLIEMLHAKRA
hide sequence
RefSeq Acc Id:
XP_006249990 ⟸ XM_006249928
- Peptide Label:
isoform X1
- UniProtKB:
A6ICJ5 (UniProtKB/TrEMBL)
- Sequence:
MSASSITGDFQDFLKHGLPAIGAGLPDRHRRPIPARSRLVMLPKVETEASGLVRSHGEQGQMPE NMQVSQFKMVNYSYDEDLEELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNQKRYTCIENQNCQIDKTQRKRCPYCRFKKCIDVGMKLEAVRADRMRGGRNKFGPMYKRDRALKQQKKALIRANGLK LEAMSQVIQAMPSDLTSAIQNIHSASKGLPLSHVALPPTDYDRSPFVTSPISMTMPPHGSLHGYQPYGHFPNRAIKSEYPDPYSSSPESMMGYSYMDGYQTSSPASIPHLILELLKCEPDEPQVQAKI MAYLQQEQNNRNRQEKLSAFGLLCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHVDYSSIISNTEVAFNNLLSLAQELVVRLRSLQFDQREFVC LKFLVLFSSDVKNLENFQLVEGVQEQVNAALLDYTLCNYPQQTEKFGQLLLRLPEIRAISKQAEDYLYYKHVNGDVPYNNLLIEMLHAKRA
hide sequence
RefSeq Acc Id:
XP_006249991 ⟸ XM_006249929
- Peptide Label:
isoform X2
- Sequence:
MVNYSYDEDLEELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNQKRYTCIENQNCQIDKTQRKRCPYCRFKKCIDVGMKLEAVRADRMRGGRNKFGPMYKRDRALKQQKKALIRANGLKLEAMSQVI QAMPSDLTSAIQNIHSASKGLPLSHVALPPTDYDRSPFVTSPISMTMPPHGSLHGYQPYGHFPNRAIKSEYPDPYSSSPESMMGYSYMDGYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQ NNRNRQEKLSAFGLLCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHVDYSSIISNTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFS SDVKNLENFQLVEGVQEQVNAALLDYTLCNYPQQTEKFGQLLLRLPEIRAISKQAEDYLYYKHVNGDVPYNNLLIEMLHAKRA
hide sequence
Ensembl Acc Id:
ENSRNOP00000000812 ⟸ ENSRNOT00000000812
Ensembl Acc Id:
ENSRNOP00000096873 ⟸ ENSRNOT00000097279
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-06-10
Nr5a2
nuclear receptor subfamily 5, group A, member 2
Name updated
70584
APPROVED
Note Type
Note
Reference
gene_function
may bind DNA as monomers and demonstrates no need for a specific ligand
68248
gene_transcript
a single copy 5.2-kb transcript
68248